Join your AesthetiCare Clinic Development Managers Rebecca, Jenny and Leanne for an exclusive 60 minute introduction and training session on the NEW ALLSKIN | MED Retinoid Portfolio featuring advanced RETINDUO® dual-pathway retinoid technology and Collagen Activation Barrier+ Treatment Plan.
With extensive experience supporting partner clinics across the UK, we’ll walk you through the latest product launches, formulation innovations and clinical technologies from ALLSKIN | MED.
What you’ll learn
NEW! Clinic-Exclusive
ALLSKIN | MED Retinoid Portfolio
Built on RETINDUO® technology, the NEW ALLSKIN | MED Retinoid Portfolio combines clinically proven retinoid innovation with evidence-based dermatological ingredients in six new products, scientifically developed to elevate the treatment of key skin indications practitioners most commonly treat in medical aesthetic clinics.
ALLSKIN | MED
Retinoid Pigment Control Emulsions
Hyperpigmentation &
Photodamaged Skin
ALLSKIN | MED
Retinoid Renewal
Serums
Ageing &
Photodamaged Skin
ALLSKIN | MED
Retinoid Texture Repair
Emulsion
Textural Concerns &
Acne-Prone Skin
NEW! RETINDUO® Technology
Dual Technology. Triple Innovation.
Forming the foundation of the NEW ALLSKIN | MED retinoid portfolio, discover Cantabria Labs’ advanced RETINDUO® dual-pathway retinoid technology, delivering triple innovation through multi-pathway retinoid activation.
RETINOL ENCAPSULATED IN MICROSPONGES
Enables controlled release and sustained activity of pure retinol within the skin.
RETINAL ENCAPSULATED WITH AOX TECHNOLOGY
Unique AOX technology delivers retinal for rapid retinoid biological activity.
NATURAL BIOAVAILABILITY BOOSTERS
Plant derived boosters designed to optimise bioavailability and enhance retinoid activity within the skin
NEW! ALLSKIN | MED
Collagen Activation Barrier+ Treatment Plan
Enhance Treatment outcomes by 50%1
Significantly reduce
redness & downtime1,2
Improve patient
comfort1,2
A clinically proven pre- and post-procedure home-care protocol specifically designed for use with ablative & non-ablative regenerative skin treatments.
Discover how to support your patients by combining the unique, patented SCA® PRO Growth Factor Technology for targeted growth factor stimulation, with Reoxderm® Antioxidant Technology for structured barrier reinforcement, maximising the skin’s regenerative response before, during and after treatment.
Who Should Join?
This session is ideal for clinic owners, managers and skincare practitioners who want to stay ahead of the curve, expand their treatment offering and ensure their team is confident with the latest innovations in retinoid and barrier protection technology.
Event Details:
Date: Tuesday, 26th May 2026
Time: 12:30 – 13:30
Format: Online Webinar (link provided upon registration)
Duration: 60 minutes
Cost: Free – exclusive to ALLSKIN | MED Partner Clinics
Reserve Your Place Now
Places are limited to ensure an interactive session. Register now to guarantee your spot.
1 Fernandez-Gonzalez P, Vitale M, Truchuelo MT. Early and maintained application of the secretion of Cryptomphalus aspersa (SCA) 40% improves cutaneous healing after ablative fractional laser in skin aging. J Cosmet Dermatol. 2020;00:1-6
2 Truchuelo, MT. Vitale, M. A cosmetic treatment based on the secretion of Cryptomphalus aspersa 40% improves the clinical results after the use of non-ablative fractional laser in skin aging, J Cosmet Dermatol. 2020;19(3):622-8.